Month: June 2021

EbixCash Announces Appointment of Renowned Economist SP Kothari to Its Board of Directors

Written by Customer Service on June 1, 2021. Posted in Public Companies.

NOIDA, India and JOHNS CREEK, Ga., June 01, 2021 (GLOBE NEWSWIRE) — EbixCash Private Limited, a subsidiary of Ebix, Inc. (NASDAQ: EBIX), a leading international supplier of On-Demand software and E-commerce services to the insurance, financial, healthcare and e-learning industries today announced the appointment of Mr. SP Kothari, as a new independent director to the EbixCash Board. Professor Kothari has senior executive experience in government, academia, and industry with expertise in strategic and policy issues, securities regulation, auditing, and corporate governance. S.P. Kothari is Gordon Y Billard Professor of Accounting and Finance at MIT’s Sloan School of Management. Most recently, from 2019 to 2021 he served as Chief Economist and Director of the Division of Economic and Risk Analysis at the US Securities and Exchange...

Dimensional Fund Advisors Ltd. : Form 8.3 – SENIOR PLC – Ordinary Shares

Written by Customer Service on June 1, 2021. Posted in Mergers And Acquisitions.

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION(a) Full name of discloser: Dimensional Fund Advisors Ltd. (“Dimensional”), in its capacity as investment manager and on behalf its affiliates who are also investment managers. Dimensional and its affiliates expressly disclaim beneficial ownership of the shares described in this form 8.3(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate...

CorVel Expands Care Advocacy Program to Provide Timely Clinical Intervention and Guidance During First Critical Days of Workers’ Compensation Claims

Written by Customer Service on June 1, 2021. Posted in Public Companies.

Newly updated nurse role improves direction and outcome of the claim, which is most often established within 30 days of the injury IRVINE, Calif., June 01, 2021 (GLOBE NEWSWIRE) — CorVel Corporation (NASDAQ: CRVL), a national provider of risk management solutions, has redesigned the Care Advocacy model by expanding the important role played by nurses in the first 30 days of a claim. The change allows for a personal and customized program for the company’s customers and their employees. Care Advocacy is the secondary nursing engagement in CorVel’s workers’ compensation program, following the Advocacy 24/7 nurse. This approach leverages CorVel’s integrated CareMC EdgeSM platform, which identifies claims involving moderate to severe worker injuries and connects a nurse care advocate within 24 hours of the first report. Unlike other...

Portable Imaging Solutions Market 2021 | Size, Share, Growth, Trends, Revenue, Competitive Analysis, Forecast Report

Written by Customer Service on June 1, 2021. Posted in Mergers And Acquisitions.

Top Players Covered in the Portable Imaging Solutions Market Research Report are Siemens, Shimadzu Corporation, GENERAL ELECTRIC COMPANY, Carestream Health, MinXray Inc., Hitachi Ltd., Neurologica Corp. and other key market players Pune, India, June 01, 2021 (GLOBE NEWSWIRE) — The global portable imaging solutions market size is anticipated to grow significantly considering the rapid adoption of mobile imaging systems. Fortune Business Insights™ in their recent report titled, “Portable Imaging Solutions Market Size, Share & Industry Analysis, By Product (X-ray, Computed Tomography (CT) Scanners, Ultrasound Systems, Others), By End-user (Hospitals & Ambulatory Surgery Centers, Specialty clinics, Diagnostic Centers, Others) and Regional Forecast, 2019-2026” discusses the vital growth trajectories in details. The report...

Indiva Reports First Quarter Fiscal 2021 Results

Written by Customer Service on June 1, 2021. Posted in Earnings Releases And Operating Results.

Indiva Achieves Record Market Share in April 2021 LONDON, Ontario, June 01, 2021 (GLOBE NEWSWIRE) — Indiva Limited (the “Company” or “Indiva”) (TSXV:NDVA) (OTCQX:NDVAF), the leading Canadian producer of cannabis edibles and other cannabis products, is pleased to announce its financial and operating results for the first quarter of fiscal 2021 ended March 31, 2021. All figures are reported in Canadian dollars ($), unless otherwise indicated. Indiva’s financial statements are prepared in accordance with International Financial Reporting Standards (“IFRS”). For a more comprehensive overview of the corporate and financial highlights presented in this press release, please refer to Indiva’s Management’s Discussion and Analysis of Financial Condition and Results of Operations for the Three Months Ended March 31, 2021, and the Company’s...

Qutoutiao Inc. Reports First Quarter 2021 Unaudited Financial Results

Written by Customer Service on June 1, 2021. Posted in Earnings Releases And Operating Results.

SHANGHAI, China, June 01, 2021 (GLOBE NEWSWIRE) — Qutoutiao Inc. (“Qutoutiao”, the “Company” or “We”) (NASDAQ: QTT), a leading operator of mobile content platforms in China, today announced its unaudited financial results in the first quarter ended March 31, 2021. First Quarter 2021 HighlightsNet revenues decreased 8.6% year-over-year to RMB1,291.0 million (US$197.0 million), while slightly decreased by 0.9% quarter-over-quarter from RMB1,302.4 million in the previous quarter, and was at the high end of the Company’s guided range. Net loss was RMB149.0 million (US$22.7 million), compared to net loss of RMB531.8 million in the first quarter of 2020 and net loss of RMB81.8 million in the fourth quarter of 2020. Net loss margin was 11.5%, compared to 37.7% in the first quarter of 2020 and 6.3% in the fourth quarter of 2020. Non-GAAP...

Claritas Announces Transfer of GVHD Program and Cancellation of Related Debt as Company Focuses on Nitric Oxide Therapeutics

Written by Customer Service on June 1, 2021. Posted in Public Companies.

SAN FRANCISCO and TORONTO, June 01, 2021 (GLOBE NEWSWIRE) — Claritas Pharmaceuticals, Inc. (TSX VENTURE EXCHANGE: CLAS and OTC: KALTF) (the “Company” or “Claritas“) today announced that it has entered into an agreement (the “Debt Forgiveness Agreement”) with the former shareholders of Talent Biotechs Ltd. (the “Talent Shareholders”), under which Claritas will transfer all assets of its program developing cannabidiol for the prevention and treatment of graft versus host disease (the “GVHD Program”) to the Talent Shareholders in exchange for forgiveness of debt and contingent liabilities. “Claritas is focused on becoming the industry leader in nitric oxide therapeutics,” stated Robert Farrell, Claritas’ President and CEO. “Our approach is to supplement the body’s natural production of nitric oxide with nitric...

Karolinska Development’s portfolio company Dilafor presents positive results from a phase 2b study of tafoxiparin

Written by Customer Service on June 1, 2021. Posted in Public Companies.

STOCKHOLM, SWEDEN 1 June 2021. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces today that the portfolio company Dilafor has concluded a phase 2b study with its drug candidate tafoxiparin which showed a significant positive impact on cervical ripening in first-time mothers receiving treatment to induce labor. Further and full analysis of data will be done by the company. Market analyses show that a drug that can induce cervical ripening has the potential to reach annual sales in excess of USD 1 billion in the US market alone. Karolinska Development will obtain an external assessment of how the positive study results affect the book value of its holding in Dilafor. About a quarter of all pregnant women are subject to labor induction, however more than half of these experience failed induction. This leads to a prolonged birth...

Visionstate Reports Q2 2021 Results Highlighted by Growing Revenues and Profitability

Written by Customer Service on June 1, 2021. Posted in Earnings Releases And Operating Results.

EDMONTON, Alberta, June 01, 2021 (GLOBE NEWSWIRE) — Visionstate Corp. (TSXV: VIS) (“Visionstate” or the “Company”), a company that develops, and invests in the research and development of, promising new technology in the realm of the Internet of Things, big data and analytics, and sustainability, is pleased to announce its second consecutive profitable quarter for the period ended March 31, 2021. Highlights of the Second Quarter of 2021 include:Total Revenue of $227,663 representing a tenfold increase compared to $20,256 during the same period in 2020. Gross Profit (Loss) of $225,218 compared to ($18,702) during the same period in 2020. Net Income (Loss) of $31,763 compared to ($192,572) during the same period in 2020.To review the financial statements and MD&A for the quarter, please click here. The development and subsequent...

Myriad Genetics Completes the Sale of Myriad myPath® Melanoma, LLC, Laboratory to Castle Biosciences

Written by Customer Service on June 1, 2021. Posted in Mergers And Acquisitions.

SALT LAKE CITY, June 01, 2021 (GLOBE NEWSWIRE) — On May 28, 2021, Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, completed the sale of its wholly-owned subsidiary, Myriad myPath, LLC, which owns the laboratory that offers the myPath Melanoma test, to Castle Biosciences, Inc for $32.5 million in cash. About Myriad Genetics Myriad Genetics, is a leading genetic testing and precision medicine company dedicated to advancing health and wellbeing for all, empowering individuals with vital genetic insights and enabling healthcare providers to better detect, treat and prevent disease. Myriad discovers and commercializes genetic tests that determine the risk of developing disease, accurately diagnose disease, assess the risk of disease progression, and guide treatment decisions across medical specialties...

Month: June 2021

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals